Foundry dNOA Factor ETF
ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Hypothetical growth of $1 — long-short backtest
Gross of the placeholder expense ratio and trading costs · not investor results
Holdings
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1APP | APPLOVIN CORP | Technology | $142.62B | 12.09% |
2BNY | BANK OF NEW YORK MELLON CORP | Financial Services | $107.85B | 9.15% |
3KDP | KEURIG DR PEPPER INC | Consumer Defensive | $42.05B | 3.57% |
4RVMD | REVOLUTION MEDICINES INC | Healthcare | $39.58B | 3.36% |
5CNC | CENTENE CORP | Healthcare | $32.81B | 2.78% |
6DXCM | DEXCOM INC | Healthcare | $29.58B | 2.51% |
7TPR | TAPESTRY INC | Consumer Cyclical | $28.58B | 2.42% |
8ECHO | ECHO GLOBAL LOGISTICS INC | Industrials | $26.66B | 2.26% |
9CPRT | COPART INC | Industrials | $25.56B | 2.17% |
10VRSN | VERISIGN INC | Technology | $25.27B | 2.14% |
11MDB | MONGODB INC | Technology | $25.12B | 2.13% |
12SYM | SYMBOTIC INC | Industrials | $24.86B | 2.11% |
13MRNA | MODERNA INC | Healthcare | $24.53B | 2.08% |
14CPAY | CORPAY INC | Technology | $23.91B | 2.03% |
15UTHR | UNITED THERAPEUTICS CORP | Healthcare | $22.74B | 1.93% |
16FTV | FORTIVE CORP | Technology | $18.83B | 1.60% |
17DD | DUPONT DE NEMOURS INC | Basic Materials | $18.49B | 1.57% |
18BBIO | BRIDGEBIO PHARMA INC | Healthcare | $15.94B | 1.35% |
19MEDP | MEDPACE HOLDINGS INC | Healthcare | $15.36B | 1.30% |
20CRCL | CIRCLE INTERNET GROUP INC | Financial Services | $15.03B | 1.27% |
21U | UNITY SOFTWARE INC | Technology | $12.66B | 1.07% |
22BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | $11.52B | 0.98% |
23HUBS | HUBSPOT INC | Technology | $11.49B | 0.97% |
24HL | HECLA MINING CO | Basic Materials | $9.61B | 0.82% |
25PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | $9.06B | 0.77% |
26OSCR | OSCAR HEALTH INC | Healthcare | $8.77B | 0.74% |
27IBRX | IMMUNITYBIO INC | Healthcare | $8.04B | 0.68% |
28RAL | RALLIANT CORP | Technology | $7.85B | 0.67% |
29MBLY | MOBILEYE GLOBAL INC | Consumer Cyclical | $7.76B | 0.66% |
30HR | HEALTHCARE REALTY TRUST INC | Real Estate | $7.39B | 0.63% |
31TAP | MOLSON COORS BEVERAGE CO | Consumer Defensive | $7.28B | 0.62% |
32MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | $7.25B | 0.61% |
33RIOT | RIOT PLATFORMS INC | Financial Services | $6.91B | 0.59% |
34FLR | FLUOR CORP | Industrials | $6.86B | 0.58% |
35CAG | CONAGRA BRANDS INC | Consumer Defensive | $6.83B | 0.58% |
36CROX | CROCS INC | Consumer Cyclical | $6.81B | 0.58% |
37CORZ | CORE SCIENTIFIC INC | Technology | $6.66B | 0.56% |
38LUMN | LUMEN TECHNOLOGIES INC | Communication Services | $6.47B | 0.55% |
39APPF | APPFOLIO INC | Technology | $6.36B | 0.54% |
40SRRK | SCHOLAR ROCK HOLDING CORP | Healthcare | $6.33B | 0.54% |
41MIDD | MIDDLEBY CORP | Industrials | $6.02B | 0.51% |
42RIG | TRANSOCEAN LTD | Energy | $5.74B | 0.49% |
43ENPH | ENPHASE ENERGY INC | Technology | $5.48B | 0.46% |
44OBDC | BLUE OWL CAPITAL CORP | Financial Services | $5.45B | 0.46% |
45RDN | RADIAN GROUP INC | Financial Services | $5.24B | 0.44% |
46STEP | STEPSTONE GROUP INC | Financial Services | $5.20B | 0.44% |
47SPHR | SPHERE ENTERTAINMENT CO | Communication Services | $5.10B | 0.43% |
48DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | $4.83B | 0.41% |
49LBRDA | LIBERTY BROADBAND CORP | Communication Services | $4.43B | 0.38% |
50VKTX | VIKING THERAPEUTICS INC | Healthcare | $4.31B | 0.37% |
51ALHC | ALIGNMENT HEALTHCARE INC | Healthcare | $4.26B | 0.36% |
52GFF | GRIFFON CORP | Industrials | $4.20B | 0.36% |
53TPC | TUTOR PERINI CORP | Industrials | $4.14B | 0.35% |
54MARA | MARA HOLDINGS INC | Financial Services | $4.08B | 0.35% |
55LION | LIONSGATE STUDIOS CORP | Communication Services | $4.03B | 0.34% |
56DOCS | DOXIMITY INC | Healthcare | $3.94B | 0.33% |
57TDS | TELEPHONE & DATA SYSTEMS INC | Communication Services | $3.90B | 0.33% |
58RLAY | RELAY THERAPEUTICS INC | Healthcare | $3.81B | 0.32% |
59DNLI | DENALI THERAPEUTICS INC | Healthcare | $3.70B | 0.31% |
60MSGE | MADISON SQUARE GARDEN ENTERTAINMENT CORP | Consumer Cyclical | $3.56B | 0.30% |
61AB | ALLIANCEBERNSTEIN HOLDING LP | Financial Services | $3.54B | 0.30% |
62GEF | GREIF INC | Consumer Cyclical | $3.52B | 0.30% |
63LBTYA | LIBERTY GLOBAL LTD | Communication Services | $3.52B | 0.30% |
64CALY | CALLAWAY GOLF CO | Consumer Cyclical | $3.48B | 0.30% |
65RNG | RINGCENTRAL INC | Technology | $3.46B | 0.29% |
66SEDG | SOLAREDGE TECHNOLOGIES INC | Technology | $3.25B | 0.28% |
67ACHC | ACADIA HEALTHCARE COMPANY INC | Healthcare | $3.17B | 0.27% |
68FSK | FS KKR CAPITAL CORP | Financial Services | $3.06B | 0.26% |
69AD | ARRAY DIGITAL INFRASTRUCTURE INC | Communication Services | $3.02B | 0.26% |
70PK | PARK HOTELS & RESORTS INC | Real Estate | $3.00B | 0.25% |
71AAMI | ACADIAN ASSET MANAGEMENT INC | Financial Services | $2.95B | 0.25% |
72DAN | DANA INC | Consumer Cyclical | $2.87B | 0.24% |
73LCID | LUCID GROUP INC | Consumer Cyclical | $2.87B | 0.24% |
74HOG | HARLEY-DAVIDSON INC | Consumer Cyclical | $2.80B | 0.24% |
75CLDX | CELLDEX THERAPEUTICS INC | Healthcare | $2.77B | 0.24% |
76VERA | VERA THERAPEUTICS INC | Healthcare | $2.76B | 0.23% |
77VISN | VISTANCE NETWORKS INC | Technology | $2.74B | 0.23% |
78NVTS | NAVITAS SEMICONDUCTOR CORP | Technology | $2.68B | 0.23% |
79KOD | KODIAK SCIENCES INC | Healthcare | $2.67B | 0.23% |
80NGVT | INGEVITY CORP | Basic Materials | $2.66B | 0.23% |
81GCMG | GCM GROSVENOR INC | Financial Services | $2.61B | 0.22% |
82PTON | PELOTON INTERACTIVE INC | Consumer Cyclical | $2.55B | 0.22% |
83IMNM | IMMUNOME INC | Healthcare | $2.53B | 0.21% |
84DRVN | DRIVEN BRANDS HOLDINGS INC | Consumer Cyclical | $2.51B | 0.21% |
85TALO | TALOS ENERGY INC | Energy | $2.49B | 0.21% |
86BCRX | BIOCRYST PHARMACEUTICALS INC | Healthcare | $2.36B | 0.20% |
87AGIO | AGIOS PHARMACEUTICALS INC | Healthcare | $2.36B | 0.20% |
88SLDE | SLIDE INSURANCE HOLDINGS INC | Financial Services | $2.35B | 0.20% |
89BHVN | BIOHAVEN LTD | Healthcare | $2.32B | 0.20% |
90FLYW | FLYWIRE CORP | Technology | $2.24B | 0.19% |
91SION | SIONNA THERAPEUTICS INC | Healthcare | $2.23B | 0.19% |
92DHC | DIVERSIFIED HEALTHCARE TRUST | Real Estate | $2.22B | 0.19% |
93AGL | AGILON HEALTH INC | Healthcare | $2.17B | 0.18% |
94GT | GOODYEAR TIRE & RUBBER CO | Consumer Cyclical | $2.10B | 0.18% |
95CDNA | CAREDX INC | Healthcare | $2.05B | 0.17% |
96SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | $2.02B | 0.17% |
97INOD | INNODATA INC | Technology | $1.99B | 0.17% |
98AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | $1.97B | 0.17% |
99GNL | GLOBAL NET LEASE INC | Real Estate | $1.96B | 0.17% |
100DMRA | DAMORA THERAPEUTICS INC | Healthcare | $1.94B | 0.16% |
101CPRI | CAPRI HOLDINGS LTD | Consumer Cyclical | $1.89B | 0.16% |
102SAM | BOSTON BEER CO INC | Consumer Defensive | $1.86B | 0.16% |
103MQ | MARQETA INC | Technology | $1.85B | 0.16% |
104NVCR | NOVOCURE LTD | Healthcare | $1.84B | 0.16% |
105FUN | SIX FLAGS ENTERTAINMENT CORPORATION | Consumer Cyclical | $1.79B | 0.15% |
106ASAN | ASANA INC | Technology | $1.77B | 0.15% |
107ZYME | ZYMEWORKS INC | Healthcare | $1.77B | 0.15% |
108BFLY | BUTTERFLY NETWORK INC | Healthcare | $1.73B | 0.15% |
109ANAB | ANAPTYSBIO INC | Healthcare | $1.69B | 0.14% |
110FTRE | FORTREA HOLDINGS INC | Healthcare | $1.68B | 0.14% |
111CMPS | COMPASS PATHWAYS PLC | Healthcare | $1.67B | 0.14% |
112TE | T1 ENERGY INC | Industrials | $1.63B | 0.14% |
113VIR | VIR BIOTECHNOLOGY INC | Healthcare | $1.59B | 0.13% |
114NTLA | INTELLIA THERAPEUTICS INC | Healthcare | $1.59B | 0.13% |
115INNV | INNOVAGE HOLDING CORP | Healthcare | $1.56B | 0.13% |
116ENOV | ENOVIS CORP | Industrials | $1.56B | 0.13% |
117CNXC | CONCENTRIX CORP | Technology | $1.49B | 0.13% |
118PRGO | PERRIGO CO PLC | Healthcare | $1.48B | 0.13% |
119TRS | TRIMAS CORP | Consumer Cyclical | $1.46B | 0.12% |
120MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | $1.45B | 0.12% |
121ECVT | ECOVYST INC | Basic Materials | $1.41B | 0.12% |
122WBTN | WEBTOON ENTERTAINMENT INC | Technology | $1.41B | 0.12% |
123FMC | FMC CORP | Basic Materials | $1.40B | 0.12% |
124CXM | SPRINKLR INC | Technology | $1.37B | 0.12% |
125AMN | AMN HEALTHCARE SERVICES INC | Healthcare | $1.36B | 0.12% |
126REAL | THEREALREAL INC | Consumer Cyclical | $1.35B | 0.11% |
127BW | BABCOCK & WILCOX ENTERPRISES INC | Industrials | $1.35B | 0.11% |
128XNCR | XENCOR INC | Healthcare | $1.30B | 0.11% |
129NSSC | NAPCO SECURITY TECHNOLOGIES INC | Industrials | $1.29B | 0.11% |
130TWO | TWO HARBORS INVESTMENT CORP | Real Estate | $1.27B | 0.11% |
131FCEL | FUELCELL ENERGY INC | Industrials | $1.25B | 0.11% |
132CCB | COASTAL FINANCIAL CORP | Financial Services | $1.20B | 0.10% |
133QDEL | QUIDELORTHO CORP | Healthcare | $1.19B | 0.10% |
134MGTX | MEIRAGTX HOLDINGS PLC | Healthcare | $1.15B | 0.10% |
135EYPT | EYEPOINT INC | Healthcare | $1.12B | 0.09% |
136SVC | SERVICE PROPERTIES TRUST | Real Estate | $1.11B | 0.09% |
137SECZ | SECURITIZE CORP | Technology | $1.11B | 0.09% |
138PCT | PURECYCLE TECHNOLOGIES INC | Industrials | $1.09B | 0.09% |
139CGEM | CULLINAN THERAPEUTICS INC | Healthcare | $1.09B | 0.09% |
140HBNC | HORIZON BANCORP INC | Financial Services | $1.04B | 0.09% |
141PCRX | PACIRA BIOSCIENCES INC | Healthcare | $1.01B | 0.09% |
142FBRX | FORTE BIOSCIENCES INC | Healthcare | $1.00B | 0.08% |
143EVC | ENTRAVISION COMMUNICATIONS CORP | Communication Services | $984M | 0.08% |
144VOR | VOR BIOPHARMA INC | Healthcare | $980M | 0.08% |
145SMPL | SIMPLY GOOD FOODS CO | Consumer Defensive | $980M | 0.08% |
146KURA | KURA ONCOLOGY INC | Healthcare | $964M | 0.08% |
147ANNX | ANNEXON INC | Healthcare | $950M | 0.08% |
148AOSL | ALPHA & OMEGA SEMICONDUCTOR LTD | Technology | $936M | 0.08% |
149APEI | AMERICAN PUBLIC EDUCATION INC | Consumer Defensive | $930M | 0.08% |
150TBPH | THERAVANCE BIOPHARMA INC | Healthcare | $873M | 0.07% |
151REPL | REPLIMUNE GROUP INC | Healthcare | $859M | 0.07% |
152NX | QUANEX BUILDING PRODUCTS CORP | Basic Materials | $835M | 0.07% |
153CYRX | CRYOPORT INC | Industrials | $832M | 0.07% |
154FOXF | FOX FACTORY HOLDING CORP | Consumer Cyclical | $798M | 0.07% |
155CODI | COMPASS DIVERSIFIED HOLDINGS | Industrials | $777M | 0.07% |
156KODK | EASTMAN KODAK CO | Industrials | $748M | 0.06% |
157CLYM | CLIMB BIO INC | Healthcare | $727M | 0.06% |
158AURA | AURA BIOSCIENCES INC | Healthcare | $723M | 0.06% |
159SPRY | ARS PHARMACEUTICALS INC | Healthcare | $695M | 0.06% |
160PKE | PARK AEROSPACE CORP | Industrials | $677M | 0.06% |
161NMFC | NEW MOUNTAIN FINANCE CORP | Financial Services | $672M | 0.06% |
162SWBI | SMITH & WESSON BRANDS INC | Industrials | $665M | 0.06% |
163CNNE | CANNAE HOLDINGS INC | Consumer Cyclical | $657M | 0.06% |
164HELE | HELEN OF TROY LTD | Consumer Defensive | $655M | 0.06% |
165EVH | EVOLENT HEALTH INC | Healthcare | $654M | 0.06% |
166ACHV | ACHIEVE LIFE SCIENCES INC | Healthcare | $644M | 0.05% |
167FAC | FACTORIAL ENERGY INC | Industrials | $610M | 0.05% |
168EVAC | EQV VENTURES ACQUISITION CORP II | Industrials | $598M | 0.05% |
169PUBM | PUBMATIC INC | Technology | $591M | 0.05% |
170NGNE | NEUROGENE INC | Healthcare | $590M | 0.05% |
171ALIT | ALIGHT INC | Technology | $584M | 0.05% |
172MYGN | MYRIAD GENETICS INC | Healthcare | $584M | 0.05% |
173RYAM | RAYONIER ADVANCED MATERIALS INC | Basic Materials | $555M | 0.05% |
174KELYA | KELLY SERVICES INC | Industrials | $531M | 0.05% |
175ARVN | ARVINAS INC | Healthcare | $517M | 0.04% |
176ADV | ADVANTAGE SOLUTIONS INC | Communication Services | $508M | 0.04% |
177OIS | OIL STATES INTERNATIONAL INC | Energy | $507M | 0.04% |
178PAYS | PAYSIGN INC | Technology | $478M | 0.04% |
179GTEN | GORES HOLDINGS X INC | Industrials | $472M | 0.04% |
180KREF | KKR REAL ESTATE FINANCE TRUST INC | Real Estate | $469M | 0.04% |
181STRZ | STARZ ENTERTAINMENT CORP | Communication Services | $450M | 0.04% |
182NEWT | NEWTEKONE INC | Financial Services | $439M | 0.04% |
183BNED | BARNES & NOBLE EDUCATION INC | Consumer Cyclical | $437M | 0.04% |
184CCRN | CROSS COUNTRY HEALTHCARE INC | Healthcare | $428M | 0.04% |
185ASPN | ASPEN AEROGELS INC | Basic Materials | $425M | 0.04% |
186BCAR | D BORAL ARC ACQUISITION I CORP | Industrials | $420M | 0.04% |
187MCFT | MASTERCRAFT BOAT HOLDINGS INC | Consumer Cyclical | $407M | 0.03% |
188NPAC | NEW PROVIDENCE ACQUISITION CORP III | Industrials | $399M | 0.03% |
189TACO | BERTO ACQUISITION CORP | Industrials | $394M | 0.03% |
190CRNC | CERENCE INC | Technology | $390M | 0.03% |
191RDAG | REPUBLIC DIGITAL ACQUISITION CO | Industrials | $388M | 0.03% |
192WENN | WEN ACQUISITION CORP | Industrials | $387M | 0.03% |
193MGPI | MGP INGREDIENTS INC | Consumer Defensive | $382M | 0.03% |
194UPB | UPSTREAM BIO INC | Healthcare | $382M | 0.03% |
195CEPT | CANTOR EQUITY PARTNERS II INC | Industrials | $376M | 0.03% |
196ZNTL | ZENTALIS PHARMACEUTICALS INC | Healthcare | $364M | 0.03% |
197SDHI | SIDDHI ACQUISITION CORP (CAYMAN ISLANDS) | Industrials | $364M | 0.03% |
198CCII | COHEN CIRCLE ACQUISITION CORP II | Industrials | $360M | 0.03% |
199TACH | TITAN ACQUISITION CORP | Industrials | $360M | 0.03% |
200IPCX | INFLECTION POINT ACQUISITION CORP III | Industrials | $359M | 0.03% |
201KCHV | KOCHAV DEFENSE ACQUISITION CORP | Industrials | $356M | 0.03% |
202SOUL | SOULPOWER ACQUISITION CORP | Industrials | $352M | 0.03% |
203OYSE | OYSTER ENTERPRISES II ACQUISITION CORP | Industrials | $350M | 0.03% |
204BLUW | BLUE WATER ACQUISITION CORP III | Industrials | $333M | 0.03% |
205SEG | SEAPORT ENTERTAINMENT GROUP INC | Real Estate | $332M | 0.03% |
206XRPN | ARMADA ACQUISITION CORP II | Industrials | $330M | 0.03% |
207RTAC | RENATUS TACTICAL ACQUISITION CORP I | Industrials | $329M | 0.03% |
208VNDA | VANDA PHARMACEUTICALS INC | Healthcare | $327M | 0.03% |
209PCAP | PROCAP ACQUISITION CORP | Industrials | $326M | 0.03% |
210OBA | OXLEY BRIDGE ACQUISITION LTD | Industrials | $325M | 0.03% |
211SZZL | SIZZLE ACQUISITION CORP II | Industrials | $325M | 0.03% |
212CRAQ | CAL REDWOOD ACQUISITION CORP | Industrials | $324M | 0.03% |
213PMTR | PERIMETER ACQUISITION CORP I | Industrials | $322M | 0.03% |
214TVA | TEXAS VENTURES ACQUISITION III CORP | Industrials | $316M | 0.03% |
215LWAC | LIGHTWAVE ACQUISITION CORP | Industrials | $308M | 0.03% |
216PSBD | PALMER SQUARE CAPITAL BDC INC | Financial Services | $306M | 0.03% |
217FHTX | FOGHORN THERAPEUTICS INC | Healthcare | $305M | 0.03% |
218ALCO | ALICO INC | Consumer Defensive | $304M | 0.03% |
219OPTX | SYNTEC OPTICS HOLDINGS INC | Technology | $302M | 0.03% |
220JENA | JENA ACQUISITION CORP II | Industrials | $301M | 0.03% |
221RAAQ | REAL ASSET ACQUISITION CORP | Industrials | $300M | 0.03% |
222BACC | BLUE ACQUISITION CORP | Industrials | $293M | 0.02% |
223PACH | PIONEER ACQUISITION I CORP | Industrials | $293M | 0.02% |
224NXDT | NEXPOINT DIVERSIFIED REAL ESTATE TRUST | Real Estate | $291M | 0.02% |
225TKNO | ALPHA TEKNOVA INC | Healthcare | $291M | 0.02% |
226JACK | JACK IN THE BOX INC | Consumer Cyclical | $286M | 0.02% |
227TVAI | THAYER VENTURES ACQUISITION CORP II | Industrials | $281M | 0.02% |
228AXIN | AXIOM INTELLIGENCE ACQUISITION CORP 1 | Industrials | $280M | 0.02% |
229PAII | PYROPHYTE ACQUISITION CORP II | Industrials | $279M | 0.02% |
230CEPO | CANTOR EQUITY PARTNERS I INC | Industrials | $271M | 0.02% |
231TRDA | ENTRADA THERAPEUTICS INC | Healthcare | $268M | 0.02% |
232ALMU | AELUMA INC | Technology | $267M | 0.02% |
233SRZN | SURROZEN INC | Healthcare | $255M | 0.02% |
234VNME | VENDOME ACQUISITION CORP I | Industrials | $254M | 0.02% |
235RILY | BRC GROUP HOLDINGS INC | Financial Services | $254M | 0.02% |
236COPL | COPLEY ACQUISITION CORP | Industrials | $248M | 0.02% |
237GTERA | GLOBA TERRA ACQUISITION CORP | Industrials | $246M | 0.02% |
238RNAC | CARTESIAN THERAPEUTICS INC | Healthcare | $243M | 0.02% |
239ARTV | ARTIVA BIOTHERAPEUTICS INC | Healthcare | $241M | 0.02% |
240SOCA | SOLARIUS CAPITAL ACQUISITION CORP | Industrials | $241M | 0.02% |
241MCGA | YORKVILLE ACQUISITION CORP | Industrials | $241M | 0.02% |
242GLSI | GREENWICH LIFESCIENCES INC | Healthcare | $240M | 0.02% |
243DAAQ | DIGITAL ASSET ACQUISITION CORP | Industrials | $239M | 0.02% |
244QUIK | QUICKLOGIC CORP | Technology | $237M | 0.02% |
245GTE | GRAN TIERRA ENERGY INC | Energy | $233M | 0.02% |
246SMTI | SANARA MEDTECH INC | Healthcare | $229M | 0.02% |
247ONEW | ONEWATER MARINE INC | Consumer Cyclical | $224M | 0.02% |
248CABO | CABLE ONE INC | Communication Services | $223M | 0.02% |
249ONCH | 1RT ACQUISITION CORP | Industrials | $222M | 0.02% |
250KPTI | KARYOPHARM THERAPEUTICS INC | Healthcare | $216M | 0.02% |
251EGHA | EGH ACQUISITION CORP | Industrials | $213M | 0.02% |
252CCAQ | COLLECTIVE ACQUISITION CORP | Industrials | $212M | 0.02% |
253IMUX | IMMUNIC INC | Healthcare | $207M | 0.02% |
254FIGX | FIGX CAPITAL ACQUISITION CORP | Industrials | $199M | 0.02% |
255SRI | STONERIDGE INC | Consumer Cyclical | $197M | 0.02% |
256COOK | TRAEGER INC | Consumer Cyclical | $193M | 0.02% |
257NLOP | NET LEASE OFFICE PROPERTIES | Real Estate | $172M | 0.01% |
258MRDN | MERIDIAN HOLDINGS INC | Communication Services | $171M | 0.01% |
259NUCL | EAGLE NUCLEAR ENERGY CORP | Basic Materials | $166M | 0.01% |
260STRS | STRATUS PROPERTIES INC | Real Estate | $165M | 0.01% |
261KORE | KORE GROUP HOLDINGS INC | Communication Services | $163M | 0.01% |
262SPEG | SILVER PEGASUS ACQUISITION CORP | Industrials | $158M | 0.01% |
263RCEL | AVITA MEDICAL INC | Healthcare | $157M | 0.01% |
264EXOD | EXODUS MOVEMENT INC | Technology | $152M | 0.01% |
265HOFT | HOOKER FURNISHINGS CORP | Consumer Cyclical | $152M | 0.01% |
266INAC | INDIGO ACQUISITION CORP | Industrials | $152M | 0.01% |
267CHPT | CHARGEPOINT HOLDINGS INC | Consumer Cyclical | $146M | 0.01% |
268WHF | WHITEHORSE FINANCE INC | Financial Services | $140M | 0.01% |
269ACNT | ASCENT INDUSTRIES CO | Basic Materials | $138M | 0.01% |
270PMN | PROMIS NEUROSCIENCES INC | Healthcare | $136M | 0.01% |
271DMRC | DIGIMARC CORP | Technology | $133M | 0.01% |
272AARD | AARDVARK THERAPEUTICS INC | Healthcare | $128M | 0.01% |
273VATE | INNOVATE CORP | Industrials | $123M | 0.01% |
274SPRB | SPRUCE BIOSCIENCES INC | Healthcare | $120M | 0.01% |
275UFI | UNIFI INC | Consumer Cyclical | $118M | 0.01% |
276WYY | WIDEPOINT CORP | Technology | $115M | 0.01% |
277STHO | STAR HOLDINGS | Real Estate | $114M | 0.01% |
278RVSB | RIVERVIEW BANCORP INC | Financial Services | $107M | 0.01% |
279CHPG | CHAMPIONSGATE ACQUISITION CORP | Industrials | $104M | 0.01% |
280CHRN | CHRONOSCALE CORP | Industrials | $94M | 0.01% |
281LCCC | LAKESHORE ACQUISITION III CORP | Industrials | $93M | 0.01% |
282ORIQ | ORIGIN INVESTMENT CORP I | Industrials | $89M | 0.01% |
283GEOS | GEOSPACE TECHNOLOGIES CORP | Energy | $88M | 0.01% |
284RLYB | RALLYBIO CORP | Healthcare | $87M | 0.01% |
285SEAT | VIVID SEATS INC | Communication Services | $78M | 0.01% |
286ACET | ADICET BIO INC | Healthcare | $76M | 0.01% |
287CLNN | CLENE INC | Healthcare | $76M | 0.01% |
288GECC | GREAT ELM CAPITAL CORP | Financial Services | $74M | 0.01% |
289NDLS | NOODLES & CO | Consumer Cyclical | $66M | 0.01% |
290BGSF | BGSF INC | Industrials | $65M | 0.01% |
291WFCF | WHERE FOOD COMES FROM INC | Technology | $63M | 0.01% |
292IMA | IMAGENEBIO INC | Healthcare | $61M | 0.01% |
293SKIL | SKILLSOFT CORP | Consumer Defensive | $58M | 0.00% |
294UYSC | UY SCUTI ACQUISITION CORP | Industrials | $56M | 0.00% |
295STEM | STEM INC | Technology | $56M | 0.00% |
296INKT | MINK THERAPEUTICS INC | Healthcare | $53M | 0.00% |
Full long-leg book as of July 2026 · cap-weighted · total market cap $1.18T. Hypothetical model holdings — not a registered fund’s portfolio.
Sector Breakdown
Portfolio Style
Size × value map of the long-leg book
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 87% toward Large, 70% toward Growth. +14% unclassified (63 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → July 2026; the right-hand end is the same value as the box’s dot. 296 names now. Hypothetical holdings — descriptive, not P&L.
Constraint checks
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Required<= 25.0%Actual25.3%Margin-0.3%Close to the line. The engine flags this verdict as one a routine data rebuild could flip. Read it as borderline rather than settled — the margin beside it is the whole story.
Days required to liquidate the largest position at 20% of one day's dollar volume.
Required<= 7.0 daysActualunboundedMargin—
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
1 verdict(s) sit within 1.0pp of their limit and can be flipped by a routine data rebuild; do not headline them, and always show the margin.
Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700
Measured on the 2026-07 formation date across 296 holdings (cap-weighted). A different formation date can produce different verdicts.
Derivatives risk (Rule 18f-4)
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months
The estimators agree, which is mild evidence the number isn’t an artefact of one method.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Since publication
Did the edge survive the paper coming out?
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Consistency across eras
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Returns
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 42.3% | 35.8% |
| 3 yearsp.a. | 25.3% | 3.4% |
| 5 yearsp.a. | 13.5% | 9.1% |
| 10 yearsp.a. | 17.7% | 6.6% |
| Since inceptionp.a. | 9.0% | 2.6% |
| Year | Long leg | Long-short |
|---|---|---|
| 20267 mo | 29.8% | 25.0% |
| 2025 | 22.7% | -0.3% |
| 2024 | 20.3% | -15.8% |
| 2023 | 35.0% | 10.4% |
| 2022 | -28.6% | 22.9% |
| 2021 | 32.7% | 25.6% |
| 2020 | 38.0% | 7.3% |
| 2019 | 36.5% | 7.4% |
| 2018 | -1.4% | 1.7% |
| 2017 | 5.0% | -16.7% |
| 2016 | 18.0% | 16.7% |
| 2015 | -3.1% | -2.4% |
| 2014 | 4.9% | 0.5% |
| 2013 | 38.3% | 6.0% |
| 2012 | 21.3% | 1.2% |
| 2011 | -8.7% | -8.0% |
| 2010 | 16.8% | -0.6% |
| 2009 | 38.9% | -16.3% |
| 2008 | -38.7% | 27.1% |
| 2007 | 5.8% | -8.7% |
| 2006 | 14.7% | 3.1% |
| 2005 | -0.1% | -5.9% |
| 2004 | 4.7% | -9.9% |
| 2003 | 51.0% | 10.9% |
| 2002 | -36.1% | -4.2% |
| 2001 | -12.3% | 13.6% |
| 2000 | -7.9% | 35.2% |
| 1999 | 25.6% | -24.3% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
Fund Facts
Methodology
The Foundry dNOA Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks (price > $5, market-cap floor) each month by a dNOA signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Documents (draft — hypothetical)
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.